Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Exova Group plc

3 Apr 2017 16:15

RNS Number : 4274B
Exova Group PLC
03 April 2017
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

EXOVA GROUP PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEREE - EXOVA GROUP PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

03 APRIL 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

-

NIL

-

(2) Cash-settled derivatives:

 

NIL

-

NIL

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

-

NIL

-

 

TOTAL:

NIL

-

NIL

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

NONE

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

3(a) Interests in Exova Group plc's ordinary shares held by directors of Exova Group plc and their connected persons

 

Director

Position

Number of shares

Percentage holding (%)

Allister Langlands

Chairman, Non-Executive Director

190,909

0.07621%

Ian El-Mokadem

Chief Executive Officer, Director

2,050,000

0.81839%

Philip Marshall

Chief Financial Officer

115,493

0.04611%

Bill Spencer

Non-Executive Director

113,636

0.04537%

Helmut Eschwey

Non-Executive Director

16,104

0.00643%

Vanda Murray

Non-Executive Director

4,545

0.00181%

Andrew Simon

Non-Executive Director

22,727

0.00907%

 

3(b) Options and awards held by directors of Exova Group plc in its ordinary shares

 

Name

Name of plan

Grant Date

Exercise Price (per ordinary share)

Shares in respect of which options granted

Performance Period End Date / Exercise Date

Ian El-Mokadem

Long Term Incentive Plan

17 April 2014

£0

153,409

17 April 2017

Company Share Option Plan

17 April 2014

220 pence

13,636

17 April 2017

Long Term Incentive Plan

15 May 2015

£0

351,562

15 May 2018

Long Term Incentive Plan

18 April 2016

£0

425,000

18 April 2019

Philip Marshall

Long Term Incentive Plan

1 October 2015

£0

153,472

1 October 2018

Company Share Option Plan

1 October 2015

180 pence

16,666

1 October 2018

Long Term Incentive Plan (not subject to performance conditions)

1 October 2015

£0

165,419

25 September 2017

Long Term Incentive Plan

18 April 2016

£0

200,617

18 April 2019

 

Notes: A total amount of £1 is payable on the exercise of any nil cost option described above. The number of ordinary shares that is capable of exercise under Mr Marshall's nil cost option granted in 2015 and Mr El-Mokadem's nil cost option granted in 2014 will be reduced by such number of ordinary shares as has a market value (at the date of exercise of the CSOP option) equal to the gain made on the exercise of the CSOP option. All awards are subject to performance conditions, save where otherwise noted.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

03 APRIL 2017

Contact name:

NEIL MACLENNANGENERAL COUNSEL AND COMPANY SECRETARY

EXOVA GROUP PLC

Telephone number:

+44 (0) 131 333 8053

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEESSEFIDFWSEFL
Date   Source Headline
15th Feb 20169:00 amRNSExova acquires majority stake in Admaterials
10th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Jan 20167:00 amRNSTrading Statement
31st Dec 201512:35 pmRNSPrice Monitoring Extension
31st Dec 20159:00 amRNSNotification of Transactions of Directors & PDMRs
18th Dec 201512:16 pmRNSAppointment of Senior Independent Director
9th Dec 20153:18 pmRNSChange of financial results date
8th Dec 201510:35 amRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSAppointment of Chief Financial Officer
11th Nov 20157:00 amRNSTrading Statement
4th Nov 201510:30 amRNSExova appoints Paul Barry as MD for Europe
3rd Nov 201511:14 amRNSNotification of transactions of Directors & PDMRs
21st Oct 20159:18 amRNSDirector/PDMR Shareholding
19th Oct 201511:51 amRNSDirector/PDMR Shareholding
13th Oct 20152:00 pmRNSExova opens Pittsburgh laboratory
5th Oct 201510:00 amRNSExova wins Qatar testing contract
2nd Oct 20159:04 amRNSNotification of transactions of Directors & PDMRs
1st Oct 201510:00 amRNSExova appoints managing director for MEAAP region
28th Sep 20157:00 amRNSAppointment of Chief Financial Officer
10th Sep 201510:23 amRNSDirector/PDMR Shareholding
8th Sep 201510:50 amRNSDirector Declaration
7th Sep 20159:30 amRNSDirector/PDMR Shareholding
1st Sep 201510:57 amRNSExova wins UAE outsourcing deal
28th Aug 20157:01 amRNSDirectorate Change
28th Aug 20157:00 amRNSHalf Yearly Report
6th Aug 20159:11 amRNSTR-1: Notification of Major Interest in Shares
29th Jul 201511:00 amRNSExova wins long term agreement
22nd Jul 201510:00 amRNSExova opens new Malaysia lab
7th Jul 201510:00 amRNSExova extends relationship with Maersk Oil
2nd Jul 20154:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20154:35 pmRNSPrice Monitoring Extension
24th Jun 20151:40 pmRNSDirector/PDMR Shareholding
23rd Jun 20151:33 pmRNSDirector/PDMR Shareholding
17th Jun 20152:50 pmRNSDirector/PDMR Shareholding
9th Jun 201511:00 amRNSExova lands Kaombo Project contract
8th Jun 20152:10 pmRNSDirector/PDMR Shareholding
19th May 201512:20 pmRNSDirector/PDMR Shareholding
14th May 20154:52 pmRNSResult of AGM
14th May 20157:00 amRNSTrading Statement
20th Apr 201512:50 pmRNSExova wins contract with AGDC
20th Apr 20157:00 amRNSChange of Adviser
10th Apr 20159:46 amRNSAnnual Financial Report
16th Mar 20153:05 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSFinal Results
24th Feb 201512:55 pmRNSTR-1: Notification of Major Interest in Shares
23rd Feb 20159:00 amRNSExova wins long term agreement with Böhler
9th Feb 201510:00 amRNSExova acquires Environmental Evaluation
4th Feb 201510:30 amRNSExova agrees calibration outsourcing deal
2nd Feb 20157:00 amRNSExova contract wins for testing on Doha Metro
22nd Jan 20159:20 amRNSNotification of New Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.